Yueh-Ming Shyu

ORCID: 0000-0002-3338-2020

Also affiliated with The University of Texas Health Science Center at Houston

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer”.

Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer

Cell Discovery(2024)10.1038/s41421-024-00720-w

N/A

0DataRank · unranked

7 citations

Yi Xiao, Jun Yao, Yunhai Li, Wendao Liu, Arseniy E. Yuzhalin +26 more

Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102363

N/A

0DataRank · unranked

2 citations

Zhengdong Liang, Cara Guernsey-Biddle, Shraddha Subramanian, Yueh-Ming Shyu, Adela M. Aldana +3 more

Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.18.660406

N/A

0DataRank · unranked

2 citations

Zhengdong Liang, Cara Guernsey-Biddle, Shraddha Subramanian, Yueh-Ming Shyu, Adela M. Aldana +3 more